Related Experiment Video
Updated: Apr 21, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Calcium in atrial fibrillation - pulling the trigger or not?
Insights
Atrial fibrillation (AF) involves disrupted calcium signaling in heart cells. This study reveals that silencing of calcium release, not instability, occurs during AF, potentially protecting cells from damage.
Area of Science:
- Cardiology
- Electrophysiology
- Molecular Biology
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia with limited treatment efficacy.
- Understanding AF mechanisms is crucial for developing new therapies.
- Current paradigms suggest Ca2+ release instability underlies AF.
Purpose of the Study:
- To investigate the role of Ca2+ signaling in atrial remodeling during sustained tachycardia.
- To challenge existing theories on the mechanisms of AF.
Main Methods:
- Studied isolated rabbit and human atrial myocytes.
- Analyzed Ca2+ signaling dynamics in response to sustained tachycardia.
- Investigated subcellular propagated Ca2+ release and cytosolic buffering.
Main Results:
- Sustained tachycardia leads to silencing of Ca2+ signaling in atrial myocytes.
- This silencing is caused by increased cytosolic buffering strength, impairing Ca2+ release propagation.
- Findings contradict the notion that Ca2+ release instability is the primary cause of AF.
Conclusions:
- Ca2+ signaling silencing, rather than instability, is a key feature of atrial remodeling in AF.
- This silencing mechanism may serve a protective role against excessive cellular Ca2+ loading in chronic AF.
- The study identifies a novel mechanism potentially relevant for therapeutic strategies in AF.
Abstract:
Atrial fibrillation (AF) is the most common sustained arrhythmia disease. Current drug- and surgical-based therapies are ineffective in about 40% to 50% of AF patients; therefore, there is a great need to better understand the underlying mechanisms of this disease and identify potential therapeutic targets. In this issue of the JCI, Greiser and coworkers discovered that atrial remodeling in response to sustained tachycardia silences Ca2+ signaling in isolated rabbit and human atrial myocytes. This Ca2+ release silencing was attributable to a failure of subcellular propagated Ca2+ release due to an increased cytosolic buffering strength. The results from this study challenge the current paradigm that Ca2+ release instability underlies AF. Instead, Ca2+ silencing could be protective against the massive cellular Ca2+ loading that occurs during chronic AF.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Electrophysiology of Normal Cardiac Rhythm

